Senior Director, Head of Translational Medicine
Pyxis Oncology
Dr. Marsha Crochiere is the Head of Translational Medicine at Pyxis Oncology, located in Boston, MA. She leads a team of scientists researching biomarkers of prediction for and pharmacodynamic response to Pyxis Oncology's first-in-concept non-cellular-targeting antibody drug conjugate PYX-201, currently being tested in a phase 1 clinical trial in a variety of solid tumors. Dr. Crochiere obtained her Ph.D. in Cell, Molecular and Development Biology from Tufts Graduate School of Biomedical Sciences and has over 10 years of experience in biotech focusing on translational medicine with the goal of bringing therapies to oncology patients with high unmet medical need.